|
Marché Fermé -
Nasdaq
22:00:00 02/09/2026
|
Varia. 5j. | Varia. 1 janv. | ||
| 34,18 USD | -0,98 % |
|
-6,99 % | +57,51 % |
| 28/08 | Roivant Sciences Ltd. annonce l'approbation de la FDA et le lancement commercial de LISRAYA pour la dermatomyosite | CI |
| 28/08 | Transcript : Roivant Sciences Ltd. - Special Call |
Principaux concurrents
Ajouter à une liste 0 sélectionné | PER (Y) | Price to Book (Y) | PEG (Y) | VE / CA (Y) | VE / EBITDA (Y) | VE / EBIT (Y) | Rendement du dividende (Y) | Capi.($) | |
|---|---|---|---|---|---|---|---|---|---|
 | -25.47x | - | -0.17x | 465.21x | -17.31x | -17.52x | -.--% | 24,69 Md | |
| 33.02x | 20.95x | 0.62x | 11.99x | 24.32x | 25.76x | 0,6 % | 1 034 Md | |
| 30.61x | 7.37x | -1.66x | - | - | - | 1,95 % | 663 Md | |
| 33.41x | -366.6x | 0.14x | 7.74x | 16.08x | 16.72x | 2,62 % | 462 Md | |
| 19.46x | 6.99x | 1.64x | 4.63x | 11.48x | 12.73x | 2,86 % | 344 Md | |
| 22.94x | 6.46x | -10x | 5.89x | 14.62x | 15.59x | 2,7 % | 307 Md | |
| 20.8x | 4.65x | 1.1x | 4.27x | 12.2x | 12.82x | 2,06 % | 251 Md | |
| 28.01x | 21.16x | 2.52x | 7.21x | 12.82x | 16.56x | 2,28 % | 239 Md | |
| 13.44x | 5.7x | -5.23x | 4.86x | 10.14x | 11.79x | 3,75 % | 207 Md | |
| -45.71x | 10.18x | 0.31x | 6.59x | 25.73x | 62.69x | 2,2 % | 186 Md | |
| 18.18x | 1.88x | 1.05x | 3.42x | 8.73x | 9.96x | 5,93 % | 165 Md | |
| 32.83x | 7.37x | 3.07x | 9.89x | 30.01x | 27.76x | -.--% | 141 Md | |
| 12.05x | 5.68x | 0.19x | 3.35x | 8.69x | 9.42x | 3,74 % | 138 Md | |
| 12.3x | 1.25x | -6.18x | 2.18x | 7.05x | 7.87x | 5,51 % | 107 Md | |
| 14.07x | 4.55x | -2.25x | 2.78x | 8.24x | 9.17x | 3,74 % | 101 Md | |
| 22.21x | 5.01x | 1.33x | 7.44x | 14.12x | 14.82x | 1,99 % | 70,85 Md | |
| 46.11x | 1.25x | 13.08x | 2.81x | 9.93x | 29.24x | 3,51 % | 58,62 Md | |
| 21.93x | 1.72x | -0.14x | 1.71x | 8.07x | 13.87x | 0,32 % | 56,01 Md | |
| 32.73x | 4.42x | 1.82x | 7.65x | 25.92x | 27.11x | 0,53 % | 44,63 Md | |
| 19x | 1.91x | 4.58x | 3.43x | 12.81x | 14.28x | 2,21 % | 43,54 Md | |
| Moyenne | 18,10x | -13,06x | 0,29x | 29,64x | 12,82x | 16,87x | 2,43 % | 232,22 Md | |
| Moyenne pondérée par Capi. | 23,48x | -27,23x | -0,47x | 10,08x | 16,53x | 19,68x | 2,18 % |
- Bourse
- Actions
- Action ROIV
- Secteur Roivant Sciences Ltd.
- Valorisations sectorielles
🔇
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
